NBSE Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NBSE shares is 23, representing 11.87% of the company's common stock.

IFP ADVISORS, INC, in the last quarter, reduced its stake in NBSE by -100% restricting it's holding to 0 shares of worth nearly N/A. DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC also lessened -100% of the NBSE shares from its portfolio, reducing its holding to 0 shares of worth N/A. N/A also shunned NBSE shares holding by N/A last quarter which brought its holding to N/A shares worth N/A.

As per its latest 13F filing, N/A increased its stake in NBSE by N/A in the last quarter. The institutional holder raised its holding to N/A shares having worth more than N/A. N/A also added N/A more shares of NBSE to its portfolio, raising its holding to N/A shares of worth N/A. N/A also increased its NBSE shares holding by N/A which brought its holding to N/A shares worth N/A.

The insider with the most stakes in NBSE is HIRSCHMAN ORIN , director at the company. Additionally, NBSE stock is highly held by Chief Executive Officer Slakter Jason Scott and director RICHMAN ERIC I among others.

Company executives, directors, and other insiders own 13.38% percent of NeuBase Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which NBSE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SYMETRYX CORP.

There have been 0 transaction(s) during the past 6-months in which NeuBase Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 NeuBase Therapeutics, Inc. shares are held by insiders, which represents about 13.38% of NBSE stock.

NBSE director, HIRSCHMAN ORIN holds the largest portfolio of the company's shares. NBSE shares owned by HIRSCHMAN total nearly 100 thousand.

CARNEGIE MELLON UNIVERSITY is the largest institutional owner in NBSE which holds 46.97 thousand shares worth $40.86K or 2.78% of the total NBSE shares outstanding followed by IFP ADVISORS, INC with ownership of 0 shares representing 0% of the NBSE ownership. DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than N/A.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NBSE is concerned, it is a stock which is not optionable.

Number of NBSE shares short is 15.57K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 3.75M shares of NBSE are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NBSE has 3.30M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NBSE is 0.24.